Physician

Ranjan Dahal, MD

According to 2025 Medicare claims, Ranjan Dahal, MD (NPI: 1194070482) practices interventional cardiology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is REGIONAL CLINICS OF LONGVIEW (NPI: 1407047863; TIN: 20-4791426) and primary practice location at 75605-2412. Dahal is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Dahal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 858 traditional Medicare patients, billed 3,234 HCPCS/CPT codes, and received $202,159 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,867 prescription claims across 462 beneficiaries totaling $446,572 in drug costs, led by Eliquis (Apixaban). DME data shows 14 claims. Open Payments data shows 31 records totaling $776. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $36,630 to $202,159. Similarly, Part D prescription costs have moved sharply higher in recent years, from $7,135 to $446,572. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $28,283 to $36,918.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	196	472	$36,630
2016	494	1,194	$91,898
2017	446	1,079	$77,250
2018	234	635	$60,858
2019	101	267	$21,561
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	228	1,253	$56,338
2024	858	3,234	$202,159

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	53	216	$7,135
2016	128	399	$15,847
2017	136	353	$17,614
2018	58	117	$6,830
2019	41	104	$5,125
2020	N/R	60	$1,324
2021	15	51	$2,202
2022	21	81	$7,668
2023	195	430	$70,098
2024	462	2,867	$446,572

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$27,829
2017	11	60	$1,902
2018	N/R	67	$1,645
2019	N/R	24	$946
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	14	$36,918

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	223	350	$88
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	227	239	$85
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	124	124	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	172	188	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	257	270	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	273	13,754	$261,987
Entresto	Sacubitril/Valsartan	46	2,070	$45,768
Jardiance	Empagliflozin	25	1,770	$34,650
Xarelto	Rivaroxaban	11	1,010	$17,843
Farxiga	Dapagliflozin Propanediol	13	930	$15,899

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	14	$36,918

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$776	Inari Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ranjan Dahal, MD?

Tedicare shows public-source Medicare data for Ranjan Dahal, MD (NPI 1194070482), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ranjan Dahal, MD have ACO affiliation data?

Ranjan Dahal, MD is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Ranjan Dahal, MD?

Ranjan Dahal, MD is linked to REGIONAL CLINICS OF LONGVIEW (billing NPI 1407047863) in the available physician profile data.

Does Ranjan Dahal, MD have Open Payments data?

Ranjan Dahal, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.